Halted trial tests direct treatment for Liver-Related brain fog
NCT ID NCT06987968
Summary
This study tested if adding a new treatment called VS-01 to standard care could help patients with severe liver disease who develop brain fog and confusion (overt hepatic encephalopathy). The treatment was delivered directly into the abdomen during a standard fluid-draining procedure. The trial was terminated early after enrolling only 3 patients, so its effectiveness remains unknown.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC ENCEPHALOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
96 Jonathan Lucas St, CSB (Main Hospital), Suite 908
Charleston, South Carolina, 29425, United States
-
Georgian Clinics" Kutaisi Referral Hospital 2, Otskheli str.
Kutaisi, 4600, Georgia
-
LEPL The First University Clinic of Tbilisi State, Medical University, Gudamakari str.4,,LEPL The First University Clinic
Tbilisi, 0141, Georgia
-
LLC Geo Hospitals Tbilisi, Multiprofile Medical Center, Tsinandali ,str. 9/3
Tbilisi, 0144, Georgia
-
Nouvel Hôpital Civil, Service de Medecine Intensive Reanimation, 1, place de l'Hôpital
Strasbourg, 67091, France
-
Tbilisi State Medical University and Ingorokva, High Medical Technology University Clinic, Tsinandali Street
Tbilisi, 0144, Georgia
Conditions
Explore the condition pages connected to this study.